Thursday, November 15, 2018
Print Current Session:
![]() |
|
Thursday
SESSION 56:
NEW AND UPDATED DEVICES FOR ENDOVASCULAR ANEURYSM SEALING (EVAS) AND EVAR FOR STANDARD AND COMPLEX AAAs (4 ½-MINUTE FAST PACED TALKS)
|
|
SESSION 56 SCHEDULE | |
8:25 AM - 8:30 AM | Downsides (Disadvantages) And Upsides (Advantages) Of Low Profile Devices For EVAR And TEVAR: There Are Tradeoffs |
Presenter(s):Michel Makaroun, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
NEW DEVELOPMENTS IN EVAS | |
8:30 AM - 8:35 AM | Update On The Nellix Endograft For EVAS: How Has Refinement Of The IFU Improved Outcomes: From The FORWARD IDE Trial |
Presenter(s):Jeffrey P. Carpenter, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:35 AM - 8:40 AM | Importance Of Good Seal Zones And Procedural Accuracy In Getting Good Results With Nellix Endografts And EVAS |
Presenter(s):Matt M. Thompson, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:40 AM - 8:45 AM | How Does EVAS With The Nellix Device Perform For Treating AAAs In Women: Data From The DEVASS Group |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:45 AM - 8:50 AM | Worldwide Update On The Nellix Endograft For EVAS: From The GLOBAL 2 Registry And EVAS IDE 2 Trial: Both Assess New Improvements In The Device And Its IFU |
Presenter(s):Andrew Holden, MBChB Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:50 AM - 8:55 AM | Value And Limitations Of Using The Nellix Endograft And EVAS To Treat Ruptured AAAs |
Presenter(s):Tal M. Horer, MD, PhD / Thomas Larzon, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:55 AM - 9:00 AM | Nellix-In-Nellix With Proximal Extension For Failed EVAS: Technique And Multicenter Results |
Presenter(s):Michel M.P. Reijnen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:00 AM - 9:05 AM | How To Preserve Hypogastric Flow With Iliac Aneurysms When Using Nellix EVAS: Technique And Results |
Presenter(s):Dainis K. Krievins, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:05 AM - 9:10 AM | Panel Discussion |
9:10 AM - 9:15 AM | All-Cause Mortality Is Lower After EVAS Than Standard EVAR: Possible Mechanisms: Is It Because Of A Decreased Post-Implant Inflammatory Response |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:15 AM - 9:20 AM | The ZFEN And ZFEN Plus Endografts From Cook For F/EVAR: Changes In The ZFEN Plus And Its Advantages, Limitations And Status In The US And Elsewhere |
Presenter(s):Jason T. Lee, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:20 AM - 9:25 AM | Long-Term Results With The Zenith Alpha AAA Endograft (From Cook): A Low Profile EVAR Device That Is Working |
Presenter(s):Thomas L. Forbes, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:25 AM - 9:30 AM | Latest 5-Year Results With The INCRAFT Device (From Cordis/Cardinal Health) For Standard EVAR: Advantages And Limitations |
Presenter(s):Andrej Schmidt, MD / Giovanni Torsello, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:30 AM - 9:35 AM | Update On The Cook P-Branch OTS Device For Treating Juxta- And Pararenal AAAs: Value, Limitations And Results |
Presenter(s):Mark A. Farber, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:35 AM - 9:40 AM | Panel Discussion |
9:40 AM - 9:55 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 56 | |
previous | next |